Literature DB >> 3262040

Synthetic peptides derived from IRBP induce EAU and EAP in Lewis rats.

H Sanui1, T M Redmond, L H Hu, T Kuwabara, H Margalit, J L Cornette, B Wiggert, G J Chader, I Gery.   

Abstract

In an earlier study we isolated three cyanogen bromide cleavage fragments of bovine IRBP that exhibited high levels of immunopathogenicity, producing inflammatory changes in the eyes (EAU) and pineal gland (EAP) of Lewis rats. These fragments have been localized within the IRBP sequence. In order to identify these putative immunopathogenic epitopes of IRBP, nine selected peptide sequences were synthesized and tested for the induction of disease in Lewis rats. Seven of the peptides were found inactive in producing disease while two closely related peptides, designated R4 (23-mer) and R9 (27-mer) were found to reproducibly induce EAU and EAP in immunized rats. No good correlation was found between the immunopathogenicity of the nine tested peptides and their amphipathicity: peptides R4 and R9 were not predicted to form strong amphipathic helices, while peptides selected for their high predicted helical amphipathicity were not immunopathogenic. EAU induced by peptides R4 and R9 was less severe and had a longer onset time than the disease induced by whole IRBP. In addition, the inflammatory changes induced by R4 and R9 in the posterior segment of the eye were less acute than those induced by whole IRBP and included granuloma formation and perivasculitis, features which are not generally seen in rats immunized with whole IRBP. Thus, the changes induced by R4 and R9 more closely resemble those which are characteristically found in human eyes affected by certain uveitic diseases than do changes produced by the intact protein.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262040     DOI: 10.3109/02713688809033202

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  8 in total

Review 1.  The natural history of uveitis.

Authors:  R B Nussenblatt
Journal:  Int Ophthalmol       Date:  1990-10       Impact factor: 2.031

2.  Rodent models of experimental autoimmune uveitis.

Authors:  Rajeev K Agarwal; Phyllis B Silver; Rachel R Caspi
Journal:  Methods Mol Biol       Date:  2012

3.  Experimental autoimmune uveoretinitis: idiotypic regulation and disease suppression.

Authors:  Y De Kozak; M Mirshahi
Journal:  Int Ophthalmol       Date:  1990-01       Impact factor: 2.031

4.  Analysis of the uveitogenic determinant in repeat structure of retinal interphotoreceptor retinoid-binding protein (IRBP).

Authors:  H Inoue; M Takeuchi; T Tanaka; M Usui; S Ando; O Taguchi
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

5.  Cellular autoimmunity to retinal specific antigens in patients with Behçet's disease.

Authors:  J H Yamamoto; M Minami; G Inaba; K Masuda; M Mochizuki
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

6.  Spontaneous development of autoimmune uveoretinitis in nude mice following reconstitution with embryonic rat thymus.

Authors:  T Ichikawa; O Taguchi; T Takahashi; H Ikeda; M Takeuchi; T Tanaka; M Usui; Y Nishizuka
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

7.  Identification of an immunodominant and highly immunopathogenic determinant in the retinal interphotoreceptor retinoid-binding protein (IRBP).

Authors:  H Sanui; T M Redmond; S Kotake; B Wiggert; L H Hu; H Margalit; J A Berzofsky; G J Chader; I Gery
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

8.  Interphotoreceptor matrix-poly(ϵ-caprolactone) composite scaffolds for human photoreceptor differentiation.

Authors:  Petr Baranov; Andrew Michaelson; Joydip Kundu; Rebecca L Carrier; Michael Young
Journal:  J Tissue Eng       Date:  2014-10-01       Impact factor: 7.813

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.